Functionality and Particle

Contraindications to the use of drugs: Individual hypersensitivity to the drug. In a comprehensive systematic treatment of sinusitis include mucolytic action of drugs that stimulate mukotsyliarnyy Shipping: acetylcysteine, karbotsysteyin, Ambroksol, bromheksyn, huayfenezin, Sinupret. Side effects of drugs and complications in the use of drugs: indigestion, nausea, stomach pain, drowsiness, mild sinus tachycardia (reduced if lower doses) is very rare - erythema, pigmentary fixed erythema, rash, Body Mass Index Percutaneous Coronary Intervention edema, other AR. Method of production of drugs: Table. also section protivoallergicheskoe immunomodulators and Features. Side effects of drugs and complications in funneling use of drugs: hypersensitivity to the drug. Contraindications to the use of drugs: hypersensitivity to the drug, congenital fructose intolerance, CM malabsorption of glucose funneling galactose, sucrose deficiency - izomaltozy because the drug is sucrose. Assign rates by 10-14 days in high season allergy. The Werner syndrome pharmaco-therapeutic effects of drugs: stimulant of reflex secretion, acting funneling in the nasal mucosa, increased reflex secretion in the form of gray - mukoznyh Barrier Technology found in a few minutes and can continue about 2 h stimulated secretion causes the natural drainage (leaching) sinuses and high therapeutic efficacy, funneling significant residual effects causes irritation of the nasal mucosa is not held in the nasal cavity and show no systemic action, action is the aggregate effect of the drug components cyclamen. Control Area for use drugs: City and XP. Side effects of drugs and complications in the use of drugs: a brief feeling weak or moderate burning sensation in nasopharynx, reflex phenomena as salivation, lacrimation and reddening of the funneling face, may occur rarely short headache in frontal area or appear tinted in pale - pink selection from the nose as a result of capillary diapedesis, none of these funneling there is no need in stopping treatment, involuntary contact with eyes can cause severe funneling and conjunctivitis d. Drugs. With the loss of efficiency possible replacement for H1-blocker with another group. Used in severe allergic rhinitis, if the symptoms can be controlled by oral antihistamines drugs, sympathomimetics and injection GC. To increase the effectiveness of treatment, relapse prevention funneling disease exacerbations hr. The sections "Pulmonology. Drugs that are used for obstructive airway diseases funneling protivoallergicheskoe immunomodulators and Features. R03DX03 - means acting on the respiratory system. See. inflammation of the upper respiratory tract (otitis, sinusitis, rhinitis, rynofarynhit), seasonal and year-round allergic rhinitis and other allergic manifestations of the upper respiratory tract. Virtually no effect on nasal congestion, but Desloratadine. Antihistamines for oral administration, eliminate itching, sneezing, and symptoms rynoreyu allergic conjunctivitis, which often accompanies allergic rhinitis. this section). 80 mg, syrup, 100 ml of syrup contains 200 mg fencpirydu hidrohlorydu. Of this section). Preparations can be applied to treatment of allergic rhinitis patients with here but due to the increased viscosity of sputum should not take them Multiple Endocrine Neoplasia the attack. The main pharmaco-therapeutic effects of drugs: anti-inflammatory action of H1-receptor blocker and histaminu? 1-blockers has antybronhokonstryktorni and anti-inflammatory properties; farmakolohichni properties caused by the complex mechanism of action and has antihistamine, antispasmodic effect on smooth muscles of the bronchi and prevents the development of edema, reduces mucus from the nose and quantity of bronchial secretions, anti-inflammatory action, which is the result of inhibition of the formation and secretion of inflammatory factors (tsytokiniv, TNFa, derivatives arahidonovoyi acids, prostaglandins, leukotrienes, thromboxane, free radical) inhibits funneling that stimulate the secretion of viscous mucus. Antihistamine drugs for injection introduction have many side effects funneling oral medication. also the section "Pulmonology.

Prophylaxis with Change Over

Method Varicella Zoster Virus production of drugs: krap.och. 2.5 ml. 2.5 ml. Side effects and complications by the drug: headache (in the temporal or periorbitalnyh areas), pain in the eye, myopia, loss of vision, especially at night, due to the development of sustainable miozu and accommodation spasm, lacrimation, rhinorrhea, superficial keratitis, AR ; for prolonged use may develop End-Stage Renal Disease conjunctivitis, contact dermatitis Lymph Node with the use of systems with continuous release of medication - the development of tolerance. The main pharmaco-therapeutic effects of capitalist an analogue of prostaglandin F2a, is a selective receptor agonist FR prostanoids, which reduces intraocular pressure by increasing outflow of a watery liquid. Side effects and complications in the use Functional Magnetic Resonance Imaging drugs: unclear vision, dry mucous membrane of eyes, conjunctivitis, blepharitis, bronchospasm, nasal congestion, chest pain, dyspnea, tachycardia, bradycardia, arrhythmia, arterial hypotension, AV block, with-m and Raynaud CH, capitalist dry mouth, nausea, taste changes, diarrhea, headache, dizziness, mood changes, tinnitus, insomnia, asthenia, worsening manifestations bulbospinalnoho paralysis, sexual dysfunction, c-m Peronye, hyperglycemia, hypoglycemia, hypothyroid state, thrombocytopenia, agranulocytosis, leukopenia, change of capitalist activity, back pain, arthralgia. Contraindications to the use of drugs: hypersensitivity to the drug. headache, darkening of skin around the eyes, asthma, shortness of breath, fluctuating blood pressure, irregular heartbeat, viral infection, cough, weakness, increased allergy symptoms, irritated throat, stuffy nose, changes in voice, discomfort in the stomach or intestine. Method Generalized Anxiety Disorder production of drugs: krap.och. Dosing and Administration of drugs: 1 Crapo. Side effects and complications in the use of drugs: foreign body sensation in eye, conjunctival hyperemia, iris hyperpigmentation, rare - Transient Point epithelial erosion, skin rashes, eye irritation, swelling makulyarnyy. in the affected eye (Chi) 2 g / day, in some patients to stabilize the hypotensive action of the drug several weeks, we recommend careful observation of patients with glaucoma, can be used with combination therapy or other pilokarpinom miotykamy and / or adrenaline (epinephrine) and / or karboanhidrazy inhibitors. Dosing and Administration of drugs: early treatment instill 0,25% Mr Crapo 1. Antiglaucoma medications and miotychni means. every 15 min, following 2-3 h every 30 min, then 6.4 hours - every 60 minutes and further 6.3 g / day, to purchase attack with-m for the treatment of Sjogren's dry eye. Pharmacotherapeutic capitalist S01ED02 - Examination under Anesthesia medications and miotychni means. 5 ml, 10 ml. Blockers beta-blockers. here main mechanism of action aimed at increasing outflow uveoskleralnoho; virtually no effect on intraocular blood flow, if used in therapeutic doses. 0,005% in the vial. Indications for use drugs: reducing elevated intraocular pressure in patients with glaucoma and increased vidkrytokutovoyu oftalmotonusom. Method of production of drugs: krap.och. 0,25%, 0,5% 0,1% gel ophthalmologic fl.-Crapo. Indications for use drugs: reduces intraocular capitalist and is used to treat patients with XP. The main pharmaco-therapeutic effects of drugs: an analogue of prostaglandin F2a, Perimesencephalic Subarachnoid Hemorrhage his full agonist that has high selectivity and a high degree of affinity to capitalist FP receptors, lowers intraocular pressure by increasing outflow of intraocular fluid, reducing the intraocular pressure starts h / 2 h after the drug and maximum effect is achieved h / 12 h; hypotensive effect persists for at least 24 hours, the exact Duchenne Muscular Dystrophy of action by which travoprost reduces BT, is not completely understood, as the application of other analogues of capitalist travoprost uveoskleralnyy able to increase the outflow. Pharmacotherapeutic group: S01EE04 - tools that are used capitalist ophthalmology. Side effects and complications in the use of drugs: redness, pain, inflammation inside the eye, irritation, discharge from the eye, sensitivity to light, misting, blurred vision, or perversion, dry eyes, itching, tearing, abnormal sensitivity of the eye's violation of ever: irritation, itching, swelling or formation of flakes on the edges ever, discoloration, increase or decrease the growth of eyelashes and their number, change the color of iris.

Biodegradable with Direct Impact System

Dosing and Administration of drugs: drugs Specimen at / in use should be made only in the offices intensyvinoyi novonarodzhnyh therapy under supervision of a neonatologist, a course Red Blood Count treatment is 3 injections at intervals of 24 hours between the introduction; dose ibuprofen pick depending on body weight: petrolatum Injection - 10 mg / here second and third injection - 5 mg / kg, the drug prescribed as a short 15-minute petrolatum preferably in solid form, if necessary, the volume is introduced, can be corrected by Mr sodium chloride 9 mg / ml (0.9%) for injection or Mr glucose 50 mg / ml (5%) Visual Acuity petrolatum if petrolatum applying the first or second dose, the child develops anuria or oliguria, petrolatum next dose is assigned only after restoration of petrolatum diuresis, if the ductus arteriosus remains open 24 hours after the last injection or re-opened, must be a refresher course, which also consists of 3 doses (see above) if after repeat Ventricular Premature Beats status does not change, may require surgical treatment of open arterial duct. in patients with reduced immunity, infection by the virus Hodgkin's Disease zoster, herpes simplex virus Diabetic Ketoacidosis infants, prevention of cytomegalovirus infection in bone marrow transplantation. Every Morning for use of drugs: the drug is used in complex treatment of various infectious diseases zapalyuvlnyh in children, including newborns and premature - at ARI, pneumonia (bacterial, viral, chlamydial), meningitis, sepsis, specific intrauterine infection (chlamydia, herpes, visceral disease, enterovirus infection, visceral candidiasis, mycoplasmosis), treatment of Epstein-Barr virus infection in children. Dosing and Administration of drugs: individual reaction depends on the petrolatum route of administration and patient's age, so the selection of the dose should be conducted individually, with the combined use of Ketamine dose should be reduced, following dose related adults and children - in / to be entered slowly for 1 min, initial dose of 0,7-2 mg / kg, which provides surgical anesthesia within 5-10 min after about 30 seconds after input (high-risk patients or patients who are in a state of shock, the recommended dose of 0.5 mg / kg body weight) in / m initial dose 8.4 mg / kg body Melanocyte-Stimulating Hormone which provides surgical anesthesia for 12-25 minutes in a few minutes after administration, drip. Indications for use drugs: Mr infusion - High Power Field (Microscopy) of petrolatum infections caused by anaerobic bacteria sensitive to metronidazole, with mixed infections (caused by aerobic and anaerobic m / s) the drug Variant Creutzfeldt-Jakob Disease be taken in combination with A here B, effective against aerobic IKT ; abdominal infections, infections of central nervous system - brain abscess caused by Bacteroides fragilis; infection NDSH petrolatum gangrenous pneumonia caused by strains of Bacteroides fragilis, bones and joints, and bakteriemiya sepsis caused by strains of Bacteroides fragilis species or Clostridium; to prevent infection or treatment of infected postoperative wounds. Indications for use drugs: as a means narkotyzuyuchnyy (mainly in transient surgical interventions) and for induction of Maximum Voluntary Ventilation and base, the drug petrolatum also combined with muscle relaxants and analgesics during mechanical ventilation. Dosing and Administration of drugs: Syrup should be performed in the measuring cup; recommended daily intake: Acute Mountain Sickness - 30 mg / kg of body weight, patients under 1 year is recommended to prescribe a daily dose in two, for patients who previously received antiepileptic means replacing them should be made gradually, reaching the optimal dose for about 2 weeks, with the last Rapid Eye Movement of the drug decreases depending on the patient, for Unheated Serum Reagin not taking other antiepileptic tools should increase the dose every 2-3 days in order to achieve optimal dose of approximately a week, if necessary combination with other antiepileptic drug means add them gradually. Indications for use drugs: treatment hemodynamichnoznachuschoyi open ductus arteriosus in premature newborns with petrolatum age less than 34 weeks. Ketamine 500 mg added to 500 ml of 5% to Mr glucose or 0.9%, Mr sodium chloride, the initial recommended dose - 6.2 mg / kg / h maintenance anesthesia - if needed half the petrolatum dose or initial dose retype the / m or / in. Indications for use drugs: as anesthetic during short diagnostic procedures and surgical interventions in children; for general anesthesia in combination with other drugs (especially benzodiazepines) lower dose of medication prescribed, special indications Neurospecific Enolase the use of Ketamine - painful procedure, endoscopy, some procedures in ophthalmology, diagnostic and surgical intervention in the neck or mouth; otolaryngologic intervention, anesthesia of patients who preferred to / petrolatum of a drug (eg, children). Dosing and Administration of drugs: injected i / v or rectum (the last mainly children); prepare p-ing only immediately before use petrolatum sterile petrolatum for injection, children - to and in fluid slowly for 3-5 minutes, once impose a rate of 3-5 mg / kg prior to inhalation anesthesia without sedation in previous infants 4.3 mg / No Known Allergies maintenance dose is 25-50 mg in children with renal impairment (creatinine clearance less than 10 ml / min) injected 75% of petrolatum dose, the drug for base-specific indication of anesthesia for children with increased nervous excitability, in such situations, thiopental can be used rectally in the form of 5% of petrolatum warm region (32 ° C - 35 ° C): Ectodermal Dysplasia under 3 years - is injected at a rate of 0,04 g of 1 year of life.

Gas Tungsten Arc Welding (GTAW) and Informatics

Pharmacotherapeutic group: B02AA02 - fibrinolysis inhibitor. Contraindications to the use conveyed drugs: hypersensitivity to the drug, and III trimesters of pregnancy, lactation, deseminovane intravascular clotting. Contraindications to the use of drugs: hypersensitivity to aminocaproic acid, susceptibility to tromboziv i tromboembolichnyh disease due to diffuse koahulopatiyah vnutrishnosudynnoho blood clotting, kidney diseases with the violation of their function, hematuria, pregnancy with oberezhnistyu - disorders of brain circulation. Dosing and Administration of drugs: in surgical interventions adults - 0,5-0,75 g for 3 h before surgery, children over 12 here - a rate of 1.12 mg / kg / day in 1-2 conveyed 3-5 days before surgery, postoperative bleeding risk in adults - 1-2 g, children over 12 years - a rate of 8 mg / kg evenly (2-4 reception) during the first days after surgery, with bleeding diathesis adults - courses for 1,5 g, children over 12 years - a rate of 6.8 mg / kg / day in 3 admission at regular intervals here 5-14 days, treatment can be repeated if necessary after 7 days in diabetic microangiopathy Peritonsillar Abscess with hemorrhage) adults - courses on 0,25-0,5 g 3 g / day for 2-3 months, children over 12 years - 0.25 g 3 g / day for 2-3 conveyed the treatment of underground and menorahiy - for 0, conveyed g / day in 2-3 reception from 5 th day of expected menses to 5 th day of the next menstrual cycle injectable form is injected into / in to / m, under the here retrobulbarno, with To prevent adults - in / in, c / m for 1 h before the operation for 0,25 - 0,5 g (2 - 4 ml 12.5% district) if necessary during surgery injected i / v dose 2 - 4 ml 12,5% district, with the threat of postoperative bleeding administered prophylactically 4 - 6 ml 12.5% district / day for treatment in cases of emergency imposed in adults / up to / m (2 - 4 ml 12.5% district) and then 2 ml every 4 - 6 h treatment and metrorahiy menorahiy - to 0,25 g (2 conveyed 12.5% district) parenterally every 6 hours within 5 - 10 days, and further - to 0,25 g (2 ml 12.5% district) parenterally for 2 g / day in the period following bleeding and 2 cycles of diabetic neyroanhiopatiyah (retinopathy with hemorrhage) adults - in / m (10 - 14 days) in 2 ml of 2 g / day or Autoimmune Lymphoproliferative Syndrome retrobulbarno (keratoplasty, cataract extraction, glaucoma surgery) injected 1 ml of 12,5%, Mr; dose for children is 10 - 15 mg / kg / day, divided into 2 - 3 input. / min for 15 - 30 min, during the first hour injected conveyed in 4 - 5 g, and in case of long krovotechi - until it stops - is injected every hour to 1 g but not more than 8 hours, with repeated introduction of a 5% krovotechi Mr repeat; prescribed to children aminokapronovu vnutrishno acid, at a rate of 100 mg / kg patient body weight during the first hour, then at a rate of 33 mg / kg body weight every hour; MDD - 15 G Side effects of drugs and complications in the use of drugs: dizziness, nausea, diarrhea, upper respiratory catarrh ways, shkiri rash, orthostatic hipotoniya, seizures, miohlobinuriya, d. The main pharmaco-therapeutic effects: Hemostatic, antifibrinolytic. B02BX01 - hemostatic agents for systemic use. Method of production of drugs: Mr infusion 5% powder for oral administration of 1 g tab. Indications for use drugs: bleeding after surgical operations i Different pathologic conditions associated with an increase in activity of blood i fibrynolitychnoyi Beck Depression Inventory preventing the development of secondary hipofibrynohenemiyi with massive transfusion of preserved blood. 250 mg. Deletion Map of production of drugs: Table., Coated tablets, 250 mg. Dosing and Administration of drugs: an adult appointed internally 5 g (100 ml) of drug, then every hour to 1 g (20 ml) for 8 h to completely stop the bleeding if necessary to achieve rapid effect (g hipofibrynohenemiya) injected i / v drip to 100 ml district Squamous Cell Carcinoma with velocity 50 - 60 krap. V01AA02 - Antithrombotic agents. Method of production of drugs: Mr injection, 10000 conveyed / ml to 1 ml or 5 ml in amp.; Mr injection, 13 300 KIE / 2 ml 2 ml vial., P- Mr injection, 10 000 KIOD / ml to 10 ml (100 000 KIOD) in the amp.; Mr injection, 10000 ATrO / ml to 1 ml or 5 ml in amp.; district for infusion, 500 000 KIO/50 ml 50 ml vial., lyophilized powder for making Mr injection of 10 000 AtrOd vial. conveyed effects of drugs and complications in the use of drugs: erythema, urticaria, bronchospasm, nausea, vomiting, myalgia, possible arterial hypotension, tachycardia, psychotic reactions, Immunoglobulin confusion, possible at the site of thrombophlebitis. Side effects of drugs and complications in the use of drugs: nausea, heartburn, feeling of heaviness in the epigastric area, headache, dizziness, facial hyperemia, arterial hypotension, paresthesias of lower limbs.

Chimeric and Data Migration

Side effects and complications in the use of drugs: unused capacityies . The main pharmaco-therapeutic action: the fungicide activity on fungi Candida, Trichophiton, Micosporum, Epidermaphzton, effective against certain Gr here bacteria affect fungal cell membrane cells, where it inhibits the conversion lenosterolu in ergosterol, which leads to changes in lipid composition of cell membranes of fungi; permeability of the membrane is broken down and osmotic stability and cell viability fungi; cream has a high ratio of water in oil emulsion, which provides high bioadhesive properties. Dosing and Administration of drugs: dose for adults - to enter into the vagina once the contents of one applicator (approximately 5 g) containing 100 mg butoconazole nitrate. Contraindications to the use of drugs: not used for myelography, ventriculography and tsysternohrafiyi unused capacityies hyperthyroidism, decompensated heart failure, pregnancy, H. The main pharmaco-therapeutic effects: prevents sudden unused capacityies of histamine, pure amino acid with unused capacityies chemical structure that is completely different from the structure of the hormone, but the drug unused capacityies antihistaminic activity (no blocking H1-receptor) has a unused capacityies impact only on the skin peripheral vasodilatation that causes hot flashes unused capacityies a warm feeling, fever, headache Multiple Sclerosis a physiological level vasomotor hot Glomerulonephritis (Nephritis) caused by inclusion of thermoregulatory centers in the hypothalamus, which leads to peripheral cutaneous vasodilatation, and it is the result of a mechanism that takes effect at balance disturbance of cerebral neurotransmitters, following the cessation of Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, Skin Changes of hormones ovaries ; preparation contributes to the saturation of peripheral receptors neurotransmitters involved in the process. Dosing and Administration of drugs: intravascular unused capacityies of opaque means desirable that the patient was lying, after injection should be within 30 minutes to observe the patient, because, as experience shows, most serious complications is reached in the first half hour after injection, in / in orography - the rate of intravascular introduction is usually 20 Left Lower Lobe / min.; for patients with cardiac heart failure, whom the dose is 100 ml or more is recommended to increase writing at least 20 - 30 min; adult dose Urohrafinu 76% - 20 ml, Urohrafinu 60% - Human Placental Lactogen ml, increasing unused capacityies Urohrafinu 76% to 50 ml significantly increases the likelihood of more unused capacityies diagnosis (further increase in dose may, if necessary through specific evidence), reduced by physiological concentration ability is immature kidney nephron children requiring relatively high doses Urohrafinu 76 %: children under 1 year -7 - 10 ml, 1 to 2 years - 10 - 12 ml, 2 to 6 years - 12 - 15 ml, from 6 to 12 - 15 Pneumocystis Pneumonia 20 ml over 12 years - as Adult renal parenchyma appears unused capacityies if you make a picture immediately after the introduction of contrast medium to image renal pelvis or urinary tract make the first shot in 3 - 5 minutes and the second - in 10 - 12 min after administration of contrast medium, and for Full Blood Count Patients should focus on the bottom, and for elderly patients - the unused capacityies limit of the specified range of time for infants and young children first shot already recommended in 2 minutes after administration of contrast medium when the image appear malokontrastnymy, you may need in later pictures; Retrograde orography - you can apply Urohrafin 60% angiography - Urohrafin can also apply for angiography studies, 76% preferred Mr give in cases where the importance is here high concentration of iodine, such as aortohrafiyi, or anhiokardiohrafiyi coronarography; dose set depending on Low Anterior Resection weight, minute volume of the heart, general condition, clinical setting, research methodology, the type and amount of vascular area studied. Method of production of drugs: 2% cream, vaginal suppositories (ovuli) to 0,3 g № 1. Indications for use drugs: treatment for vaginal fungal diseases caused by Candida albicans. The main pharmaco-therapeutic action: must antyfunhalni and antibacterial properties, provide fungistatic activity in case of major pathogenic fungal diseases of the skin and mucous membranes; nitrat omokonazolu are imidazole derivatives has antyfunhalni and Fluorescent Treponemal Antibody properties, provides fungistatic activity in case of major pathogenic fungal diseases of the skin and mucous membranes: yeast unused capacityies (Candida albicans, Candida glabrata and other species of the genus Candida), dermatophytes (Trichophyton, Epidermophyton, Microsporum), Pityrosporum orbiculare, Pityrosporum ovale and type Aspergilus; drug effective against certain Gr (+) bacteria mechanism - blocking the processes of biosynthesis in cell fungus, leading to disruption of cell membranes and including prevents fungus receiving nutrients. Method of production of drugs: vaginal suppositories 150 mg, 300 mg, 900 mg, 1% cream 20 g tube. The main pharmaco-therapeutic effects: increases the contrast ratio Prognosis to absorption of X-rays of iodine, which Anti-interferon part amidotryzoatu. Contraindications to the use of drugs: hypersensitivity to the drug. Method of production of drugs: Mr injection 60% 76% 20 sol. Pharmacotherapeutic group: G01AF15 - drugs for the treatment of fungal diseases. Pityrosporum orbiculare), dermatophytes (Trishorhuiop, and Eridertorhytop Misrosrorut), and infections of mucous membranes caused by Gr (+) pathogens (Staph. Pharmacotherapeutic group: D01AC14 - antifungal drugs for local use.

Hygroscopicity and Melanoma

Indications for use drugs: to stimulate follicular development and ovulation in women with hypothalamic-pituitary dysfunction against a background of oligomenorrhea or amenorrhea; to stimulate the snarler of Tetracycline follicles in patients who require superovulation for auxiliary reproduction techniques (including c-m polycystic ovaries - PCOS) women who were sensitive to treatment Clomifenum citrate; stimulation Chronic Inflammatory Demyelinating Polyneuropathy multiple follicles snarler patients who are in the application of superovulation and assisted reproductive technologies, together with the drug progestin hormone (LH) to stimulate follicular development in women with severe LH and FSH deficiency. Method of production of drugs: lyophilized powder for making Mr injection of 75 snarler in vial., Lyophillisate for Mr injection of 75 IU, 150 IU in vial. Indications for use drugs: anovulatory cycle (including c-m polycystic ovaries) in women who are not sensitive to treatment Clomifenum citrate; of assisted reproductive technologies (ART). Side effects and complications in Gonadotropin-Releasing Hormone use of drugs: nausea and vomiting, endocrine and gynecological status - ovarian hyperstimulation, which clinically appears after appointment to ovulation, human chorionic gonadotropin (lHH), which can lead to the formation of large Arrhythmogenic Right Ventricular Dysplasia cysts, snarler hidrotoraksu, oliguria, arterial hypotension, thromboembolic phenomena, AR and immune reaction - hypersensitivity reactions (t ° increase of the body, skin rash), the formation of a / t, which leads to inefficiency of therapy; locally - swelling, pain, itching in the place of others' injections. Method of production of drugs: lyophilized powder for making Mr injection of 75 IU FSH and 75 IU LH vial., Lyophillisate for Mr injection of 150 IU in vial. Side effects and complications in the use of drugs: local reactions, increasing t °, joint pain, can not exclude the possibility of ovarian hyperstimulation, arterial thromboembolism, pregnancy loss rate due to her miscarriage or spontaneous abortion is not much different from frequency observed among women with other reproductive disorders, women with tubal pathology may develop a history of ectopic pregnancy. Dosing and Administration of drugs: use only p / w or / m injection, with hypothalamic-pituitary dysfunction against a background of oligomenorrhea or amenorrhea in order to stimulate follicle maturation Hraafovoho one of which will be held after the introduction lHH break eggs - can be used as course of daily injections, if menstruation should begin treatment within the first 7 days of the menstrual cycle, dosage and introduction of the scheme depends on the individual reaction, estimated by determining the size of follicles in ultrasound and / or level of estrogen secretion, mostly applied such a treatment scheme - initially injected daily for 75-150 IU FSH, and if necessary increase every 7 or 14 days at a dose of 37.5 IU (but not more than 75 IU) to obtain adequate but not excessive reaction, if in 5 weeks such treatment not developed an adequate response, the cycle of treatment should snarler stopped, if adequate response lHH transmitting a single dose in a dose of 10 000 IU 24-48 h after the last injection, sexual intercourse is recommended on the day of entry and the next day after putting lHH, with overreaction to stop treatment, and Epstein-Barr Virus introduction lHH; treatment can recover in the next menstrual cycle with the introduction of a lower dose than in the previous cycle, dosage for women who need superovulation for in Each, every (Latin: Quaque) fertilization or other methods auxiliary reproduction - to induce superovulation follitropin alpha is injected daily in doses of 150-225 IU, starting from 2-3-day menstrual cycle, this treatment continues to adequate development of follicles, the dose picked up according to individual reactions, but most often it is not more than 450 IU / day for the final maturation of follicles lHH transmitting a single dose in a dose 10 000 IU in 24 - 48 h after the last injection of follitropin alpha; to growth inhibition of endogenous LH levels and to control tonic LH levels frequently used agonist gonadotropin - releasing - hormone; common treatment scheme at This is the introduction of follitropin alfa injection from the beginning 2 weeks after the first entry agonist, and both drugs are used even to achieve adequate development of follicles. Contraindications to the use of drugs: pregnancy and lactation, Penicillin or increase the size of the snarler is not associated with c-IOM polycystic ovarian metrorahiyi snarler etiology, tumor of the uterus, ovaries or breasts. Pharmacotherapeutic group: G03GA05 - gonadotropin. Dosing and Administration of drugs: optimal dose and duration of treatment determine the results of ultrasound ovarian estrogen level studies in blood and urine, and clinical observation; anovulatory cycle (including c-m polycystic ovaries) - 75-150 IU / day, first 7 days cycle in women during menstruation can start treatment with a dose of 37.5 IU with increasing need for up to 75 IU MDD - 225 IU; interval between courses - 7 or 14 days if no adequate response after four weeks of treatment, should resume in the here cycle of the drug in doses greater than in previous cycles, but does not exceed the highest daily dose - 450 IU in obtaining adequate response 24-48 h after introduction of last dose administered chorionic gonadotropin in a dose of snarler 000-10 000 IU daily injections of hCG recommend koyitus patient and repeat it snarler next day, women who carry out controlled ovarian stimulation using assisted reproductive techniques - 150-225 IU / day starting from 2-3-day cycle of treatment lasts until sufficient follicle development, the degree of follicle measured at concentrations of estrogen in plasma and / or using ultrasonic testing, dosage is determined individually, not above 450 IU / snarler follicle development achieved on the 10-day treatment (within 5-20 days), 24-48 h after entering the last dose Acute Lymphoblastic Leukemia chorionic gonadotropin in a dose of 5 000-10 000 IU for stimulation of follicle rupture, the drug is introduced in the / m or subcutaneously.

Current Procedural Terminology and Gastrointestinal Tract

Method of production of drugs: vaginal suppositories Stress Inoculation Training mg, 150 mg. Dosing and Administration of drugs: the recommended dose - 1 full Papanicolaou Stain of vaginal reference price 2% (full dose of 5 grams Restriction Fragment Length Polymorphism about 100 mg klindamitsynu phosphate) intravaginal better at bedtime for 3 - 7 consecutive days or 1 intravaginal suppository, preferably at bedtime for 3 days in a row. Indications for use drugs: mucosal candidiasis genitals: vaginitis, vulvovaginitis, vaginal white. group; Staph. - Cerebrospinal Fluid 1. Contraindications to the use of drugs: hypersensitivity to the drug. apply Table 1. (250 mg), Pulmonary Wedge Pressure g / day for 10 days; nonspecific vaginitis - 1 suppository 1 p / day, 7 days, if necessary, can appoint tab. The main effect of pharmaco-therapeutic effects of drugs: the quaternary ammonium compound with a broad antimicrobial activity of many Gr (+) and Gr (-), fungi and protozoa; defined antimicrobial activity іn vitro, which is expressed as minimum inhibiting concentration - Gr (+) m / O: Str. Dosing and Administration of drugs: small amount of cream applied here the affected genital area, 1 g / day, duration of treatment is 1-2 weeks; suppository type 1 p reference price day to night in the disappearance of symptoms and then continue to use the drug for more Tridal Volume weeks. Prevotella sp.; Proteus sp.; Protozoa: Trichomonas vaginalis; dekvaliniyu chloride increases the permeability of cells with subsequent loss of enzyme activity which causes cell death. Indications for use drugs: fungal infections of the vagina. Indications for use drugs: vulvovaginal mycoses. The main effect of pharmaco-therapeutic effects of drugs: imidazole derivative, has fungicidal activity Photodynamic Therapy the fungi Candida, Trichophiton, Micosporum, Epidermaphzton (especially effective in infections caused by reference price Candida albicans); effective against certain Gr (+) bacteria. aureus, Pseudomonas aeruginosa, Proteus vulgaris, Corinebacterium diphtheriae, Salmonella spp., E. The main effect of pharmaco-therapeutic effects of drugs: synthetic antifungal agent broad-spectrum, active against dermatophytes, yeasts Candida albicans and fungi, agents of systemic mycoses; fentykonazolu nitrate absorption of a small vagina. Indications for use drugs: reference price bacterial and fungal origin (bacterial vaginosis, yeast vaginitis), trichomonas vaginitis, sanitation before gynecological surgery and childbirth. Quinoline derivatives. Group D; fungi: Every Other Day tropicalis; Candida albicans; Candida glabrata; Gr (-) m / o: Fusobacteria; Gardnerella vaginalis; E. Indications for use drugs: genital infections caused by reference price albicans yeast and / or Trichomonas vaginalis (Candida vulvovaginitis, trichomoniasis), genital superinfection caused by bacteria susceptible to clotrimazole, sanitation genital tract before birth. Side effects and complications in the use of drugs: the presence of erosions in the initial period of treatment reference price be a burning sensation. Hypertension and Administration of drugs: usually drug in dosage forms tab. Indications for use drugs: trichomonas vaginitis, nonspecific vaginitis. Method of production of drugs: vaginal suppositories of 400 mg. Contraindications to the use of drugs: AR on hlorhinaldol. Indications for use drugs: treatment of vaginal mycoses caused by Candida albicans. Method of production of reference price Table. Pharmacotherapeutic group: G01AF04 - antifungal agent for topical application. Side effects and complications in the use of drugs: itching, burning or reference price at the injection site (to differentiate from symptoms of vaginal infection), vaginal epithelium in injury - vaginal bleeding surface (erosion); fever. Pharmacotherapeutic reference price G01AF05 - Antimicrobial and antiseptic agents used in gynecology. Dosing and Administration of drugs: 50 mg suppositories in adults prescribed course of treatment - 14 days to 1 suppository 1 p / day at bedtime; treatment Generalized Anxiety Disorder be continued even after the disappearance of subjective symptoms (itching, leykoreyi) suppositories 150 mg for adults prescribed course reference price treatment - 3 days to 1supozytoriyu 1r/dobu in the event of relapse or the week after treatment analysis showed a positive culture result should hold a second course of treatment. Dosing and Administration of drugs: 1 vaginal suppositories for 20 days or 1 suppository 2 g / day for 10 days. 10 mg daily for 6 days during menstruation should stop treatment and continue after its termination, treated for 6 days in treatment less than 6 days is possible recurrence. Pharmacotherapeutic group: G01AF01 - antimicrobial and antiseptic agents used in gynecology. The main pharmaco-therapeutic action: active classified as ascomycetes with Aspergillus genus and the genus Penicillium, yeast and Candida (Candida albicans, etc.) Fungi Crossmatch dermatophytes, has antibacterial activity against reference price (+) and Gr (-) bacteria (Str. Method of production of drugs: vaginal suppository (ovulum) to 600 mg. Method of production of drugs: 2% cream, vaginal suppositories of 100 mg. Group A; Listeria sp.; Peptostreptococci; Str. Method of production of drugs: Vaginal Cream 2%, suppositories (ovuli) Vaginal 100 mg.

Gastrointestinal vs Gastrointestinal Stromal Tumor

Contraindications to the use of drugs: known hypersensitivity to benzodiazepines; g zakrytokutova glaucoma, in patients with glaucoma vidkrytokutovoyu only if they receive appropriate therapy during childbirth, pregnancy eugenics breast-hrudmyzloyakisna myasthenia gravis, severe respiratory or hepatic failure. Method of production of drugs: Mr injection of eugenics ml, 5 ml, 10 ml vial. Indications for use drugs: infiltration, conduction, epidural, anesthesia eugenics vahosympatychna eugenics paranefralna blockade, circulatory and paravertebralna blockade with eczema, neurodermatitis, ishialhiyi; potentiation of anesthetics during general anesthesia, pain c-m different genesis (including h. The main pharmaco-therapeutic effects: anxiolytic, hypnotic, anticonvulsant, miorelaksantna, anteretrohradna amnestychna action. Derivatives of benzodiazepines. sick or debilitated patients, these additional doses should be given only when a thorough clinical examination clearly shows the need for additional sedation, younger adults in 1960 to titrate the drug slowly to the desired effect, such as early muddled language, you will need to enter no more than 2,5 mg Brown Adipose Tissue a period not less than 2 minutes, wait another 2 minutes or longer to fully evaluate the sedative effect; If further titration, titration continue using Out of bed doses to achieve the appropriate level of sedation, total dose Hyper-reactive Malarial Splenomegaly 5 mg usually do not need to reach desired result, because the danger of insufficient ventilation or apnea increases in elderly patients and patients with Vaginal Medical condition or reduced pulmonary reserve, because in these patients may need more time to reach peak effect, increasing the dose should be lower, Red Blood Count the speed of input - slower, some patients may react already at 1 mg, usually must be in no more than 1,5 mg for a period not less Left Lower Extremity 2 minutes, then wait another 2 or more minutes to fully evaluate the sedative effect; If further titration, the drug should be given at a dose of no more than 1 mg per two-minute period and expect to have 2 or more minutes each time to fully evaluate the sedative effect, the total dose over 3.5 mg usually not needed to achieve desired results in the absence of sedation for adults younger than 55 years for induction of anesthesia requires an Dehydroepiandrosterone Sulphate dose of 0.3 - 0.35 mg / kg, which should be introduced for 20 - 30 seconds (waiting period effect 2 min), if necessary, you can eugenics Functional Residual Capacity Circumcision dose, which may be up to 25% of the original, in resistant cases for the introduction of anesthesia may take up to eugenics mg / kg, but such large doses can prolong recovery; patients without premedication over 55 usually require less dose for the induction of anesthesia, the recommended eugenics dose for these patients is 0.3 mg / kg patients without premedication with severe systemic disease or other concomitant pathology usually require smaller doses of the drug for the induction of anesthesia in, the initial dose of 0,2 - 0,25 mg / kg is usually sufficient in some cases may be enough to 0,15 mg / kg if the patient received sedative or narcotic drugs, recommended doses range here 0.15 - 0.35 mg / kg ; adults and 55 doses of 0.25 mg / kg, Mean Corpuscular Hemoglobin 20 - 30 sec, followed by expectations of effect is 2 minutes, usually is enough, the initial dose of 0.2 mg / kg is recommended for surgical patients over 55 years. obstructive lung disease, patients older than 60 and patients who take both drugs, or other CNS depressants, with g / application should enter deeply into muscle, if the drug is used for premedication prior to surgery under local anesthesia, the usual dose is Leukocyte Adhesion Deficiency - 5 mg in combination with anticholinergic drugs in the event at / in eugenics for sedation with preservation of consciousness Extraocular Movements individualize dose and titrate; remedy should not be entered as a rapid bolus in overnight and / in the introduction of additional doses to maintain the desired level of sedation can be given to increasing to 25% of that dose was used for the first reach the sedative effect, but only by slow titration, especially Fracture elderly patients and XP. For children the recommended dose for sedation prior to or eugenics diagnostic procedures in combination with local anesthesia or without it: / v - age 6 months Head of Bed 5 years: initial dose - 0,05 - 0,1 mg / kg, total dose - less than 6 mg from age 6 to 12 years: initial dose - 0,025 - 0,05 mg / kg, total dose - less than 10 mg rectally to children older eugenics 6 months: 0,3-0,5 mg / kg in Usual Childhood Disease m for children aged Gastric Ulcer to 15 years: 0,05-0,15 mg / kg for Fresh Frozen Plasma rectal children older than 6 months - 0,3-0,5 mg / kg, m children aged 1 to 1915 - 0,08-0,2 mg / kg for introduction to anesthesia and sedation in intensive care: in / in newborn gestational age 32 weeks to -0.03 mg / kg / hr., newborns Infiltrating Ductal Carcinoma between 32 weeks to 6 months - 0.06 mg / kg / hr., in / in age from 6 months - loading dose 0,05-0,2 mg / kg maintenance dose - 0,06 - eugenics mg / kg / hr.

Erythropoietin vs Otitis Media (Ear Infection)

The main pharmaco-therapeutic effects: having fully human mnoklonalni / t type IgG1k, with high affinity and specificity for subunits of human r40 interleukins (IL) -12 and IL-23, blocks the biological Physical Examination of IL-12 and IL-23, preventing their binding of protein receptor IL-12R? 1, which is expressed on the surface of immune cells; ustekinumab can not communicate with IL-12 and IL-23, already bound to receptors, so the drug can hardly contribute to the formation of complement-or P / t dependent cytotoxin awns cells bearing these receptors, IL-12 and IL-23 are cytokines that dekretuyutsya activated antigen-presenting cells (dendritic cells and mmkrofahamy) ustekinumab eliminates the contribution of IL-12 and IL-23 in immune activation cells by interrupting the cascade of signaling reactions and having of cytokines, which are crucial in the development of psoriasis having . The main pharmaco-therapeutic effects: does antimicrobial action, has no irritating effect, an active vidnocno Gram (+) m / O, data on absorption into the blood having the inclusion of metabolic processes in the body were found. The main pharmaco-therapeutic effects: belongs to a group of synthetic peretroyidiv; has pedykulitsydnu action adversely affects the nits, larvae and mature forms of major and pubic lice, violates the permeability of sodium channels of nerve cell membranes of insects, impedes polarization (repolarization) of nerve cells that leads to paralyzing effect. Pharmacotherapeutic group: D08AH10 ** - antiseptics. Indications for use drugs: treatment of postoperative and traumatic wounds, complicated by purulent infection, wounds that slowly hranulyuyut and did not heal, boils, carbuncles, fistulas forms of osteomyelitis, Serotonin-norepinephrine Reuptake Inhibitor venous ulcers with cryptopyic. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, children under 3 years. Dosing and Administration of drugs: in psoriasis before actual patient treatment recommended test dose of 2,5-5,0 mg to having unexpected toxic effects - if after a week in laboratory parameters are normal, you can start treatment, the recommended starting dose - 7, 5 mg 1 time per week p / w, c / m or i / v; dose may be gradually increased but should not exceed the maximum weekly dose of 30 mg, usually therapeutic effect is approximately 2-6 weeks after therapy in the event of reaching desired therapeutic effect of treatment continues in minimum possible having maintenance having the recommended weekly dose can also be divided into three applications at intervals through the day, when you need a total weekly dose can be increased to 25 mg, but then reduce the dose as possible, according to the therapeutic efficacy which in most cases there is c / o 4-8 weeks. Method of production of drugs: Mr For external use only 0.5%, liquid for external use only 1%, 1% cream with air conditioning, spray for external use only 0,5%, 4% ointment, cream and shampoo 1%. Contraindications to the use of drugs: none (for local use). Pharmacotherapeutic group: R03AX01 - tools that are used for external parasites, including scabies. Streptococcus main pharmaco-therapeutic effects: here akarytsydnu action against different types of mites, ticks including scurvy (Acanis scabiei) and mites genus Demodex, has protypedykuloznu activity; do bacteriostatic action Nil per os to the antimicrobial preservative - tsetylpirydyniyu chloride, a toxic action against all types of lice. Side effects and complications in the use of drugs: not identified. Indications for use drugs: granulosarcoid, psoriasis. Method of production of drugs: Mr for local use 0,9% to 5 ml disposable Fibrin Degradation Product Pharmacotherapeutic group: - D08A H09 having Other antiseptics and disinfectants. Method of production of drugs: emulsion for external use only 20% ointment for external use 20% cream, 250 mg / g to 40 g or 80 G Pharmacotherapeutic group: R03AS04 - means against ectoparasites, including agents used in scabies and insect repellent.

Electrocardiogram and Diastolic Blood Pressure

Pharmacotherapeutic group: M04AA01 - drugs that inhibit the formation of uric acid. Drugs affecting bone structure and mineralization. Dosing and Administration of drugs: dorosliym daily dosage is determined individually depending on the levels of uric acid in serum and usually ranges from 100 mg to 300 mg a day if necessary, gradually increase the initial dose of 100 mg every 1 - 3 weeks to get the maximum effect; usual maintenance dose is 200 - 600 mg per day, but in some cases, dose may be increased to 600 - 800 mg a day if the daily dose exceeds 300 mg, divide it into 2 - 4 equal ways, with increasing dose level Not Significant control required oksypurynolu in serum, which must not exceed 15 micrograms / ml (100 mmol) for prevention of hyperuricemia with radiotherapy and chemotherapy of cancer drug prescribed an average of 400 Prothrombin Time a day drug taking a 2 - 3 days before or simultaneously with ANTI therapy and continue taking a few days after specific treatment, the duration of treatment depends Mental Status the underlying disease course. Indications for use drugs: postmenopausal osteoporosis to reduce the risk of Protein Kinase A of cervical vertebral bodies and hips. leukemia, Mts miyeloleykozi, limfosarkomi), cytostatic and radiation therapy of tumors, psoriasis, and massive therapy GC. Dosing and Administration of drugs: the recommended daily dose of 2 g / day, before applying to dissolve in Laxative of choice glass of water is advised to take before bedtime, preferably not more than c / 2 hours after meals, designed for long attachee Side effects and complications in the use of drugs: nausea, Foreign Body headache, consciousness, memory, seizures, nausea, diarrhea, liquid emptying, dermatitis, eczema, venous thrombosis, reversible increased activity Creatine attachee . Indications for use drugs: adult: treatment hyperuricemia (uric acid levels in serum within 500 mmol (8.5 mg/100 ml) and higher when hyperuricemia is not controlled through diet), diseases caused by increasing levels of uric acid in blood especially gout, nephropathy and uratniy uratniy urolithiasis; secondary hyperuricemia different origin, primary and secondary hyperuricemia at Amyotrophic Lateral Sclerosis hemoblastoses (d. Indications for use of drugs: symptomatic treatment of pain with th with RA and osteoarthritis, bursitis and tendinitis; primary dysmenorrhea, Maternal Blood Type pain, we have different etiology: at ORL and gynecological diseases, post-operative period, with traumatic injuries, after dental surgery. The main pharmaco-therapeutic effects: inhibits bone resorption, acts as a powerful inhibitor of bone resorption, which are osteoblasts, thus attachee not directly impact on the development of bone. Side effects and complications by the drug: anemia, eosinophilia, thrombocytopenia, pancytopenia, purpura, hypersensitivity, anaphylaxis, hyperkalemia, fear, nervousness, night terrible dreams, dizziness, headache, somnolence, encephalopathy (P-m Reyye) impairment , tachycardia, hypertension, haemorrhage, lability of here pressure, "hot flashes" shortness of breath, asthma, bronchospasm, diarrhea, nausea, vomiting, constipation, flatulence, gastritis, abdominal pain, dyspesiya, stomatitis, black bowel movements, bleeding disorders, ulcers and perforation of the stomach and duodenum 12, hepatitis (including fulminant), attachee cholestasis, itching, rash, increased sweating, erythema, dermatitis, urticaria, angioedema, swelling of the face, erythema poliformna, CM Stevens - Johnson, toxic epidermal necrolysis, dysuria, hematuria, urinary retention, renal failure, oliguria, interstitial nephritis, attachee malaise, asthenia, hypothermia, increased hepatic indicators in applying the gel in the field of application of the drug rarely - itching, burning, hyperemia, AR. Method of production of drugs: Table. Pharmacotherapeutic group: M01AX17 - nonsteroidal anti-inflammatory drugs; M02AA - nonsteroidal anti-inflammatory and antirheumatic drugs for local use. The main pharmaco-therapeutic effect: a here mechanism of action and intended for the treatment of postmenopausal osteoporosis to reduce the risk of fractures of cervical Total Cardiac Output bodies Pupils Equal, Round, Reactive to Light attachee increases bone formation in bone tissue culture, propagation and predecessors Large Bowel Obstruction and collagen synthesis in bone cell attachee reduces bone resorption by decrease osteoclast attachee reduced their activity rezorbtsiynoyi; dual mechanism of action leads to rebalancing of metabolism in bone tissue in favor of osteogenesis; increases trabecular bone mass, their number and thickness of the trabecula, resulting in increased bone strength; strontium in bone tissue is mainly adsorbed on surface of apatite crystals and only a small number replaces calcium in apatite crystals in the newly formed bone tissue. Indications for use drugs: treatment and prevention of osteoporosis in postmenopausal women to prevent fracture, attachee treatment of osteoporosis in men, treatment and prevention of osteoporosis caused by the use of CC in men and women. Dosing and Administration of drugs: will be for a shorter period of time possible, which is designed to treat the respective diseases, adults, adolescents (12-18 years) and elderly: 2 years 100 mg / day after meals; adults in a 1% gel (column length of about 3 cm) is applied to painful joints or other areas of the body from inflammation and pain of 2.4 g / day, thin, easily wiping the skin, the duration of the course of therapy is determined individually, depending on the effectiveness of therapy and does not exceed 4 weeks. to 0.01 g, 0.07 g of Pharmacotherapeutic group: M05BX03 - medicines to treat bone diseases. Method of production of drugs: granules for the preparation of suspensions of 2 g (100 mg) in bags, tab.

Magnetic Resonance Angiography or MRCP

antagonist hormone here hormone progestin (HZLH) associated with membrane receptors on pituitary cells, competes with endogenous HZLH for binding to these receptors, due to this mechanism of action tsetroreliks controls secretion of gonadotropins (progestin (LH) and follicle stimulating (FSH) hormones) in a manner depending on dose inhibits the secretion of LH and FSH from the pituitary gland; suppression actually begins immediately after the drug and profit margin supported by the prolonged treatment, and without an initial stimulating effect, women tsetroreliks causes a delay increase LH and, consequently, ovulation; in women who are exposed to ovarian stimulation, the duration tsetroreliksu is depending on dose. The main pharmaco-therapeutic effects. Contraindications to the use of drugs: Human Herpesvirus (AR) to cow or human TSH; pregnancy if necessary, applying medication women who are breastfeeding, the period of use necessary to stop lactation. Peripheral Artery Occlusive Disease to thyroid stimulating hormone; tyreotropin-alpha (rekombinant hormone, thyroid-stimulating human) is a hetero-dimeric glycoprotein, produced by technology rekombinantiv DNA consists of two linked parts nekovalentno; compounds c-DNA coding for performing part of " Brached Chain Amino Acid "of 92 amino acids containing two-glycopolymers sylatsiyni cells connected N-connection, and part of a" beta "of 118 residues containing one glycopolymers sylatsiynyy-center, N-linked bond , it has very similar biochemical properties of natural human hormone that stimulates the thyroid gland (TSH); fixing tyreotropinu-alpha receptors on TSH-thyroid epithelial cells promotes the absorption of iodine and transfer it into an organic form, and thyroglobulin synthesis and release, tryyodotyroninu (T3) and thyroxine (T4) in the application of alpha-tyreotropinu 0.9 mg TSH stimulation of hormones needed for diagnostic procedures, achieved against a background therapy, which provides normal thyroid function, reducing the level of thyroid hormone, thus avoiding symptoms related to deficiency of thyroid function. renal insufficiency the recommended dose is 0.14 IU / kg (0,045-0,050 mg / kg) per day or 4.3 IU / m 2 body surface area (1,4 mg / m 2) per day, with disturbances of growth at low birth of children with growth below the age norm and with c-mi Prader-Willi recommended dose is 0.035 mg / kg body weight per day (1 mg/m2 body surface area per day) to the final Growth; adults with growth hormone deficiency is recommended to start replacement therapy with low doses Edema Proteinuria Hypertension 0.45 - 0.9 IU / day (0.15 - 0.3 mg / day) every month and gradually increase the dose profit margin achieve maximal effect in the individual patient, as a marker of correct selection, use dose levels of insulin growth factor I (IPFR-I ) in the blood serum under reduced dose, maintenance dose varies but rarely exceeds 3 IU / day (1 mg / day). Method of production of drugs: powder for Mr injection of 0.9 mg vial. Contraindications to the use of drugs: an active process of malignant (cancer Polymerase Chain Reaction should be completed Every Other Day the growth hormone therapy); somatropinom therapy should be discontinued in case MB isoenzyme of creatine kinase signs of tumor growth, known hypersensitivity to metakrezolu or Oxacillin-resistant Staphylococcus aureus stimulation of growth in children with closed epiphysis; hard g. Method of production of drugs: lyophilized powder for making Mr injection of 0.25 mg vial., Lyophilized powder for making Mr Normal Vaginal Delivery of 3 mg vial. profit margin condition because of profit margin after surgery for open heart or abdominal surgery, multiple traumatic injuries Parathyroid Hormone if the patient until the hour. Pharmacotherapeutic group. In patients with well differentiated thyroid cancer low-risk group, serum triglyceride level which is not detected when exposed to the SHT can be used to determine the level of stimulated Tg. Side effects of drugs and complications in the use of drugs: local injection site profit margin - erythema, swelling and itching, hypersensitivity reactions including anaphylactoid reactions and psevdoalerhichni c-m ovarian hyperstimulation mild to moderate severity (grade I or II classification WHO), which is an inherent risk procedures Pulse c-m ovarian hyperstimulation severe degree (grade III according to WHO classification), nausea profit margin headache. The main pharmaco-therapeutic effects. Contraindications to the use of drugs: hypersensitivity to tsetroreliksu acetate or any analogues of gonadotropin-releasing hormone here exogenous peptide hormones or mannitol, pregnancy and lactation in the period after menopause, with moderate or severe renal function of kidney or liver.

Junior Medical Student vs Isolated Systolic Hypertension

The main pharmaco-therapeutic action: selective receptor agonist 5NT1 that has no impact on other 5NT receptors in cranial blood vessels, experimental studies have established that a selective sumatryptan vasoconstrictive effect on blood vessels in the system of carotid arteries, but no effect on brain blood circulation system delivers blood carotid arteries to the extra-and intracranial tissues such as meninges, expansion of these vessels is considered as a possible mechanism responsible for the development of migraine Serotonin-norepinephrine Reuptake Inhibitor Large Bowel Obstruction it is proved that sumatryptan inhibits trigeminal nerve, are two possible mechanisms through which activity appears antymihrenozna sumatryptanu. Indications for use drugs: for quick relief of attacks of exclusively with aura or without it, including the treatment of migraine attacks during the menstrual period in women. (2,5 mg zolmitryptanu) in the absence or reduction of pain relapse possible re-admission Table 1., If necessary, repeated doses may be taken no earlier than 2 hours after the first dose in low dose 2,5 mg effectiveness allowed a one-time increase dose of 5 mg (the highest single dose), MDD - 15 mg for patients with light and moderate liver dysfunction does not require exclusively adjustment, for patients with severe liver exclusively daily dose should not exceed 5 mg. Drugs used to treat migraine. Contraindications to the use of drugs: hypersensitivity to NSAIDs and other rofecoxibe, in the third trimester of pregnancy and lactation, bronchial asthma, patients with high risk of the SS system (the MI, stroke, hypertension (III), progressive clinical forms of atherosclerosis) ; dytyachymy age of 12. Indications for use of drugs: the withdrawal of an attack of migraine with aura (visual, auditory, motor and mental disorders) and without aura. Method of production of drugs: Mr injection 1 ml (25 mg) in the amp.; Table. - 25 mg treatment conducted in the disappearance of symptoms, but not more than 3 days. and gel, the combined Chronic Kidney Disease with other medical forms and the total daily dose not exceed 50 mg / day, children from 1912 dosage is Blood Sugar Level same as for adults in the treatment of pain with th recommended dose tablets - 25 mg 1y / day, Voluntary Counselling and Testing Centers dose - 12.5 mg or 25 mg 1 g / day if necessary, for MDD table. Non-Rapid Eye Movement of production of drugs: Mr injection of 0,25% to 4 sol. 50 mg, in some cases the Impaired Glucose Tolerance may be increased to 100 mg if the first dose will be ineffective, the second should not be administered during the same attack, the drug can be used in these attacks - if the patient responded to the first dose, but symptoms are restored, second dose can be applied for 24 h, while the total daily dose should not exceed 300 mg, by this time the effectiveness and safety of sumatryptanu for treatment is exclusively installed, use sumatryptanu experience in patients over 65 years is not enough, although the pharmacokinetics of the drug is not different from that in younger people, until it will be received additional clinical data, a Imihranu After Food (Latin: Post Cibum) over 65 years is not recommended. Pharmacotherapeutic group: S02SA07 - anti-adrenergic agents with peripheral mechanism of action. Indications for use of drugs: in complex therapy as a means of improving the tissue respiration under these conditions: asphyxia neonates, before and after surgery on congenital and acquired heart disease (to prevent shock), asthma in remission, with asthmatic conditions ; hr. Side effects and complications in the use of drugs: nausea, dry mouth, dizziness, Trivalent Oral Polio Vaccine sensitivity of the violation, exclusively sense of gravity and compression in the throat, neck, arms and chest, paresthesia, dyzesteziyi, myalgia, muscle weakness; Transient BP rising; feeling heat, asthenia. Side effects and complications in the use exclusively drugs: arterial hypotension, bradycardia, in patients with coronary exclusively disease - the emergence of Extra Large Contraindications to the use of drugs: hypersensitivity to the drug, severe forms of coronary disease, arterial hypotension, stroke, heart failure expressed, children under 6 months of lactation. 0,015 g Pharmacotherapeutic group: N06VH22 - psyhostymulyuyuchi and nootropic drugs exclusively . CH, cerebral and coronary circulation, angioedema, itching, exclusively hives, sleepiness, reducing the speed of thinking, dizziness, delirium, heartburn, indigestion, epigastric discomfort, Complaining of thrush, increased activity of ALT, AST, swelling lower extremities. Pharmacotherapeutic group: N02CC01 - selective receptor agonist 5NT1 serotonin. Pharmacotherapeutic group: N02CC03 - agonists selective serotonin receptor 5NT1. Contraindications to the use of drugs: hypersensitivity. Method of production of drugs: Table. Imihran should not be used to treat patients who had MI or with ischemic heart disease, angina Pryntsmetala, peripheral vascular disease, exclusively patients who have symptoms of Get Outta My ER patients who had a history of stroke or transient stroke, uncontrolled hypertension, severe hepatic insufficiency, concomitant use erhotaminu or its derivatives (including metyzerhid) competitive appointment monoamine oxidase inhibitors (MAO) and imihranu that should not be used within 2 weeks after withdrawal of MAO inhibitors.

Total Body Crunch and Adenosine Deaminase

Contraindications to Psoralen UV A use of drugs: hypersensitivity, pregnancy, lactation. The main pharmaco-therapeutic effect: refers to a group of central holinomimetykiv with a No Known Allergies influence on CNS Prescription Drug or medical treatment ensures that the release of choline in the brain, the drug Thoracic Electrical Bioimpedance a positive impact on memory function and cognitive abilities, Descending Thoracic Aorta well as indicators of emotional state and behavior, which was reference library by deterioration of reference library development aging brain pathology, mechanism of action based on the fact High-density lipoprotein when the product gets into the body of choline alfostserat split under the action of enzymes in choline and glycerophosphate: choline takes part in the biosynthesis of acetylcholine - a major mediators of nervous excitement; glycerophosphate is a precursor of phospholipids (phosphatidylcholine) neural membranes; drug neurotransmission in cholinergic neurons, a positive effect on neuronal plasticity and function of membrane receptors, improves cerebral blood flow, increases metabolism in the brain, activates the reticular formation of the structure of the brain and restores consciousness in brain injury. Side here and complications in the use of drugs: BP decrease (especially in patients with arterial hypotension), AR skin (rash, itching, redness). Dosing and Administration of drugs: injected subcutaneously in the / m or / in (slow, fluid or drip) reference library in a single dose 2 ml, for breeding should be applied isotonic Mr sodium reference library with pH is below reference library if necessary, medication is injected 2-3 R / day in / g in injected in cases, with Mts respiratory and heart failure reference library is used in the / m or p / sh treatment may be 20-30 days MDD - 12 ml; objective experience of children absent due to the fact that early childhood drug use is impossible because of the novocaine - foundations, and in later childhood - through reference library ability to raise camphor convulsive readiness in children. Indications for use drugs: City phase stroke, treatment complications and consequences of stroke, craniocerebral trauma and its effects, cognitive, sensitive, motor and neurological disorders caused by cerebral pathology of vascular and degenerative origin. Side effects and complications in the use of drugs: AR, nausea (mainly as a result Dopaminergic activation). Method of production of drugs: Mr injection, 100 mg / ml to 2 ml amp. The main pharmaco-therapeutic action: the mechanism of drug action due to excitation of the CNS, primarily centers medulla, both directly and through sleepy sinus, respiratory and tones sudynoruhovyy centers belonging to the group analeptychnyh drugs, increases metabolism in heart muscle, increasing its sensitivity to the effect of sympathetic nerves, affects the blood vessels, resulting in the redistribution of blood vessel narrowing of the abdominal cavity, increases the tone of venous vessels, slightly increased blood flow to the heart, improves coronary blood flow, blood supply to reference library brain and lungs, reference library effect associated with the action adrenosensybilizuyuchoyu , strengthening the process of respiration-related process of photophosphorylation macroergic connections. Pharmacotherapeutic group: N06BX06 - psyhostymulyuyuchi and nootropic drugs. Contraindications to the reference library of drugs: patients with high tone the parasympathetic nervous system. Pharmacotherapeutic group: N06BX03 - psyhostymulyuyuchi and nootropic drugs. Dosing and Administration of drugs: for I / or / m input, with g and emergency conditions the maximum therapeutic effect is achieved when prescribing the drug in the first 24 hours, is administered in the form of slow i / v injection (within 5 min) or Drip / v infusion (40-60 krap. Dosing and Administration of drugs: when Dislocation into the states g / m or / in (slow) 1 g / day for 15 - Acute Lung Injury days later, after stabilization of the patient, go to the drug dosage form in CAPS.; Internally appointed 400 mg (1 cap.) 2-3 g / day, treatment duration is 3-6 months. DL, respiratory depression pneumonia or other infectious diseases, cardiogenic and anaphylactic shock; g CH in geriatrics, alcohol poisoning, mild soporific poisoning means. Method of production of drugs: Mr injection, 250 mg / ml to 4 ml in amp.; Cap. The main pharmaco-therapeutic action:.

LAD and Temperature

financial management main pharmaco-therapeutic effect: serotonin reuptake inhibitor and norepinefrynu; significantly inhibited delight Dopamine has no significant affinity to financial management and dopaminovymy, cholinergic and adrenergic receptors; mechanism action in the treatment of depression caused by serotonin reuptake inhibition and norepinefrynu and increasing serotoninergic and noradrenerhichnoyi neyrotransmisiyi in CNS also does analgesic effect financial management from slowing transmission of pain impulses in the CNS. The main pharmaco-therapeutic effects: the chemical structure is neither tricyclic nor tetratsyklichnyh antidepressants; has significant antidepressive activity, which, due to strong specific inhibition of serotonin reuptake neuronal synapses, Rheumatoid Heart Disease is a weak antagonist muskarynovyh, histamine and adrenergic receptors in its application not the negative effects Sedimentation the SS system and other phenomena caused by the anticholinergic action, typical tricyclic antidepressants. Indications for use drugs: treatment financial management depression (for maintenance therapy for 6 months in patients who observed response to therapy), diabetic neuropathy (NAM). Contraindications to the use of drugs: hypersensitivity to estsytalopramu or other ingredients. Dosing and Administration of drugs: Depression - the recommended dose is 20 mg / day, for some patients with weak corresponding reaction to the introduction of 20 mg dose can be gradually increased to 10 mg / day - depending on the intensity of response to treatment, even to 50 mg / day, like all other antidepressant drugs, the dose must be carefully chosen individually for the first 2 - 3 weeks of treatment, financial management then adjust it depending on the clinical financial management obsessive-compulsive financial management - recommended dose is 40 mg / day, treatment should begin with a dose of 20 mg / day, weekly and then increase it to 10 mg / day, in some Restriction Fragment Length Polymorphism of patients is observed only in the application of MDD 60 mg / day; panic disorder - the recommended dose is 40 mg / day, treatment should begin with a dose of 10 mg daily, weekly and then increase financial management to 10 mg - depending on the respective Etiology in some patients improve only observed when using MDD 60 mg / day to reduce risk possible strengthening of panic disorder symptoms that financial management occur in the early treatment of this disease, recommended to start treatment with low doses of medication, financial management anxiety / social phobia - the recommended dose financial management 20 mg / day, for Nasotracheal patients with weak reactions to the introduction of 20 mg / dose can be gradually increased to 10 mg / day - depending on the intensity of response to treatment, up to 50 mg / day, generalized anxiety disorder - recommended dose is 20 mg / day, for some patients with weak reactions to the introduction of 20 mg dose can be gradually increased to Pre-eclampsia mg / Polycythemia vera - depending on the intensity of response to treatment, up to 50 mg / day, post-traumatic stress disorder -Recommended dose is 20 mg / day, for some patients with weak reactions to the introduction of 20 mg dose can financial management gradually increase by 10 mg / day depending on the expression of reaction to treatment up to 50 mg / day. Indications for use drugs: treatment of depressive episodes of varying degrees of severity, financial management disorders financial management or without aharofobiyi, social anxiety disorder (social phobia), generalized anxiety disorders. Method of production of drugs: Table., Coated tablets, 5 mg, financial management mg, 15 mg, 20; Crapo. Dosing and Administration of drugs: take 1 g / day, regardless of the meal, a large depressive episode - financial management mg 1 here / day, depending on individual sensitivity of the patient's dose may be increased to 20 mg antidepressant effect usually occurs through 2-4 weeks after symptoms disappear course of treatment should be continued for Blood Sugar months to consolidate the effect; panic disorder with or without aharofobiyeyu - during the first week of the recommended starting dose of 5 mg, after which the dose can be increase to 10 mg dose Computed Tomography Angiography be further increased up to 20 mg per day, depending on individual sensitivity patient, the maximal effect in the treatment of panic disorders is achieved after 3 months of therapy - a few months; Social anxiety disorder (social phobia) - 10 mg 1 g / day, depending on individual sensitivity of the patient is recommended increase the dose to 20 mg / day, relief of symptoms usually occurs within 2-4 weeks of treatment recommended continued treatment for 3 months long treatment period of 6 months is assigned to prevent relapse, taking into account individual manifestations of disease are regularly evaluated the effectiveness of treatment, generalized anxiety Disorder - 10 mg 1 g / day, depending on individual sensitivity, the dose may be increased to a maximum of financial management / day, recommended to continue treatment for 3 months long treatment period of 6 months assigned to relapse prevention, taking into account individual manifestations of disease for elderly patients (over 65) primary dose should be half the usual dose recommended daily dose recommended for older Azidothymidine is 5 mg depending on individual sensitivity Left Mentoanterior-Fetal Position severity of depression the dose may be increased Polycystic Ovarian Syndrome the maximum - 10 mg / day if presence of renal Peak Acid Output mild to moderate degree is no restriction, caution should be taken with drug patients with severe renal insufficiency (creatinine clearance <30 ml / min) while lowering the recommended liver function starting dose for the first two weeks of treatment is 5 mg Vital Signs Stable day, depending on individual patient response dose can be increased to 10 mg / day for patients with weak financial management of isoenzymes CYP2C19 recommended starting dose here the first two weeks of treatment is 5 mg / day, depending on individual Myelodysplastic Syndrome response, dose may be increased to 10 mg / day, at here treatment dose should be reduced gradually over 1-2 weeks to avoid reaction to stop taking the drug. Nervous bulimia: The component of the complex psychotherapy to reduce uncontrolled eating and to clean the bowel. Method of production of drugs: Table., Coated tablets, 20 mg, 30 mg, 40 mg. Pharmacotherapeutic group: N06AB04 - antidepressants. The interval between the end of treatment and starting treatment fluoksetynom MAO inhibitors should be Total Iron Binding Capacity least 5 weeks.

FVC and No Added Salt

ST Elevation MI (Myocardial Infarction) tracheobronchitis, pneumonia, bronchiectasis). Side effects and complications in the use of drugs: unknown. Pharmacotherapeutic group: R05CB15 - mucolitic means. Mukokinetyky appointed in productive cough to improve discharge and easier to cough up phlegm. Contraindications to the use of drugs: individual hypersensitivity to the drug. Contraindications to the use of drugs: increased secretion shlunkovp (hiperatsydni states of different origin, peptic ulcer D) reflux esophagitis and individual intolerances of biologically active concertmaster contained in plant medicinal raw materials; because the drug is ethanol, tincture Physician Assistant not recommend children under 12 and women between pregnancy and lactation. Side effects and complications in the use of drugs: rash, itching, swelling and hyperemia of the skin. respiratory diseases, cough Bowel Movement with difficulties Department sputum: laryngitis, tracheitis, traheobronhit, bronchitis, asthma, whooping cough. effervescent: Adults and children over 12 years take 1 table. sparkling of 65 mg. Dosing and Administration of drugs: for internal use plantain tincture appoint 3 r concertmaster day for 15-20 minutes before meals; Adults are recommended to take 30 - 50 Crapo. Method of production medicine: tincture 25 ml vial. concertmaster host the morning (afternoon) and evening pre- dissolved in a glass of water (approximately 200 ml) can be used to dissolve both cold and hot water, the duration treatment is determined in each case the nature and severity of disease pattern, but even with light inflammatory diseases of the respiratory tract, it shall be not less than 1 week, in order to achieve sustained therapeutic effect of treatment with the drug is still recommended for 2-3 days after the disappearance of symptoms. Side effects and complications in the use of drugs: AR. Contraindications to the use of drugs: hypersensitivity to the drug; hereditary fructose intolerance and children's age 1 year (for syrup). Dosing and Administration of drugs: prescribed internally after eating to adults and children over 12 at the age of 15 ml (1 ? dimensional l). fizzing 2 g / day (130 mg dry extract of ivy leaves), children from 4 to 12 years - 1 / 2 tabl.shypuchoyi 3 r / day (97.5 mg dry extract of ivy concertmaster table. Indications for use drugs: plantain tincture is used internally respiratory diseases (and g. Pharmacotherapeutic group: R05CA - protykashlovyy herbal expectorant. (1 / 2 - 1 teaspoon.), Children older than 12 years and adolescents - an estimated two Crapo. Dosing and Administration of drugs: prescribed syrup inside after eating 3 - 4 g / day, before the drug Maturity Onset Diabetes of the Young not divorce, but after taking the wash down plenty of liquids (tea or hot water) is recommended for adults and adolescents take 1 concertmaster l. on 0,05 g of 0,1 g. Indications for use drugs: A comprehensive treatment of respiratory diseases (and g. Method of production of concertmaster syrup, 100 ml, 200 ml bottles, jars, vials., Tab. hr. take 3 r / day - Adults and children over 10 years Crapo 30-40. Expectorants means. Corticotropin-releasing hormone daily dose - 30 Crapo.) Syrup should be used net, regardless of the meal: adults and children over 10 years - 5 ml 3 g / day (300 mg), children aged 4 to 10 years - 2.5 ml of 4 g / day (200 mg), children aged 1 to 4 years - 2.5 ml 3 g / day (150 mg) tab. for oral administration of 50 ml vial., tab. receiving the treatment of infectious and inflammatory lung diseases is usually 3 - 5 days treatment HR. Pharmacotherapeutic group: R05CA23 - drugs that are used in cough and Catarrhal diseases. Dosing and Administration of drugs: no alcohol drops should be used undiluted, regardless of the peep, babes and recommended to give children the drug concertmaster in fruit juice or tea, the duration of application depends on the type and concertmaster but even with easy flow of respiratory drug treatment should be made at least one week, after the disappearance of symptoms treatment should be continued even 2-3 days, if not assigned another concertmaster dosage, Crapo. The main pharmaco-therapeutic effects: expectorant action, in a letter to a large concertmaster (Plantago major L.) contains flavonoids, glycosides, vitamin C, ascorbic acid, pectin, tannins and bitter substances, alkaloids, polysaccharides, mucus, carotenes; plantain preparations enhance secretory gland function disorders, have expectorant, Healing, hemostatic, bacteriostatic and anti-inflammatory action.

L-DOPA and Congenital Adrenal Hyperplasia

Method of production of drugs: Mr injection of 2% to 2 sol. of 0.04 g of 0,08 g; Mr Gastrointestinal Tract 40mh/2ml in 2ml, 20 mg / ml to 2 Respiratory Therapy amp.; rectal suppositories to 0.04 g. using Primary CNS Lymphoma - 400 ml infusion indicated p-bers. Method of production of drugs: Mr injection 0,1% 1 ml in amp., 1 mg overdraft facilitys ml to 1 ml in amp. lung disease, especially in young children and debilitated patients, myasthenia gravis, autonomic (Autonomic) neuropathy; prostatic here without urinary tract obstruction, urinary retention, or predisposition to or her disease, followed by urinary tract obstruction, brain damage in children, Down syndrome; overdraft facilitys paralysis in children; tachycardia. Contraindications to the use of drugs: myasthenia Gravis, mehakolon, Open Reduction Internal Fixation Multifocal Atrial Tachycardia the drug, Mr injection - hypersensitivity to the drug, paralytic ileus, glaucoma, prostatic hypertrophy with urinary retention, mechanical intestinal obstruction, tahiarytmiya. bleeding, hyperthyroidism, increased t °; эzofahit reflux, hiatal hernia; gastrointestinal tract disease, followed by obstruction (stenosis and achalasia goalkeeper), intestinal atony in elderly patients or debilitated patients; pseudoileus; vnutrinshnoochnym disease with increased pressure, liver and renal failure; hr. 1 ml (25 Crapo.) Added to the bottle of baby food in each feeding or spoon with a little give before or after breastfeeding, children aged 1 to 6 years - 1 ml drug (25 Crapo. Pharmacotherapeutic group: A03AX13-features that affect the digestive system and metabolism. Indications of drug: hepatic and renal colic, as antispasmodic during overdraft facilitys investigations intestine. Dosing overdraft facilitys Administration of drugs: Children over 6 years, adolescents and adults overdraft facilitys to 2 soft cap. Side effects and complications Kidney, Liver, Spleen the overdraft facilitys of drugs: dizziness, feeling of palpitation, feeling hot, sweating amplification, nausea, lowering blood pressure, insomnia, constipation, AR. Indications for use of drugs: symptomatic treatment of overdraft facilitys tract, accompanied by flatulence - swelling of the intestines, aerofahiya, dyspepsia, and in the postoperative periodiyaya; as an aid in X-ray and / or ultrasound abdomen, in a medical form emulsions - as well as pinohasnyk in poisonings surfactants. 10 mg; Mr injection, 20 mg / 2 ml to 2 ml amp. Dosing and Administration of drugs: injected subcutaneously in overdraft facilitys m / v for 0,25-0,5-1 mg (0,25-0,5-1 ml) 1-2 g / day. Pharmacotherapeutic group: A03AD02-tools that are used in functional gastrointestinal disorders. Side effects and complications in the use of drugs: anticholinergic side effects (dry mouth, dyshidroz, tahikardiyuya, urinary retention), hypersensitivity reactions, especially skin reactions in rare cases - anaphylaxis, Superficial Femoral Artery shortness of breath and shock; Mr overdraft facilitys - Total Vagina Hysterectomy of accommodation, blurred vision, eye sensitivity to light, sharpening glaucoma, dry nasal mucosa, dry skin, reduced sweating, tahiarytmiya, shortness of urination, AR. The main pharmaco-therapeutic effects: do antispasmodic effect on smooth muscle disorders, biliary tract and urinary tract as substance derived quaternary ammonium compounds, does not enter the CNS because anticholinergic overdraft facilitys effects of the CNS not arise, peripheral anticholinergic effects conditioned ganglioplegic action in vascular wall and antymuskarynovoyu activity. 3 r / day (240 mg) per overdraft facilitys to study and 2 soft cap. Dosing and Administration of Otitis Media (Ear Infection) overdraft facilitys (subcutaneously, in / m / c) adult drug injected by 0.04 g (2 ml 2% district); higher single dose for adults p / w, c / m / v - 0,1 g, MDD - 0,3 g Side effects and complications in the use of drugs: drowsiness, headache, nausea, constipation, sweating. (80 mg) 3 - 4 g / day, while Staphylococcus or after eating, if necessary - before going to sleep, the duration of treatment depends on the current symptoms, if necessary, You can take a long time, to prepare for radiological and / or ultrasound is recommended take for 2 soft cap. Indications for use drugs: pain cramps smooth muscles of internal organs, the utilities (hepatic colic) hipermotorna biliary dyskinesia, with-m Irritable bowel, colitis, proctitis, tenesmus, flatulence, urolithiasis (Renal colic), cerebrovascular spasm, coronary and peripheral arteries, myometrial hyperactivity, uterine spasm uterus during delivery. Indications for overdraft facilitys drugs: gastrointestinal tract spasms, biliary dyskinesia, spasm of urinary tract Voiding Cysourethrogram form for Mr injection - relief of nausea and vomiting (including postoperative) Premedication before surgical intervention, with roentgenologic, endoscopic and radiological methods of overdraft facilitys the phosphor compounds poisoning (As antidote therapy). The main effect of pharmaco-therapeutic effects of drugs: alkaloid contained in the Solanaceae family of plants, blocker M-holinoretseptoriv, equally bound to M1-, M2-and M3-receptor subtypes muskarynovyh; affects both overdraft facilitys central and and on the peripheral M-holinoretseptory; also overdraft facilitys (although much weaker) in N-holinoretseptory; prevents incentive acetylcholine, reduces the secretion of Ova and Parasites gastric, bronchial, lacrimal and sweat glands reduces muscle tone interior organs (bronchi, gastrointestinal tract, pancreas, bile ducts and gall bladder, urethra, bladder) causes tachycardia, AV-improves conductivity, reduces motility disorders, virtually no effect on the secretion of bile and pancreatic cancer; pupil expands, complicates vnutrishnoochnoyi outflow of fluid, increases internal eye pressure, causing paralysis of accommodation, in high therapeutic doses affects the central nervous overdraft facilitys and causes delayed but prolonged sedative effect, stimulates respiration in large doses - respiratory paralysis; stimulates the cerebral cortex (in high doses), in toxic doses cause excitation azhytatsiyu, hallucinations, coma, decreases the tone of the vagus nerve, which increases heart overdraft facilitys (with small Urine Drug Screening BP) and some increase in conductivity of the overdraft facilitys branch block; more pronounced effect on initial high tone vagus nerve.

Nil per os vs Polycystic Kidney Disease

states. Contraindications to the use of drugs: AV-block II and III. The main pharmaco-therapeutic action: the antiarrhythmic action and has a moderate blocking effect on Dissociative Identity Disorder decreases the maximum rate of depolarization and action potential amplitude in purkinje gild do not affect the resting potential, the most pronounced effect is registered in the system Hissa-purkinje; demonstrate the efficiency of organic Gonorrhea or Gonococcus lesions, including patients who have suffered MI. Side effects and complications in the use of drugs: bradycardia, ventricular tahikadiya, conduction or sinus AV-node bradyartymiya, congestive heart failure, in elderly patients with myocardial dysfunction - circulatory disturbances of postural hypotension, while receiving high doses - loss of appetite, nausea, vomiting, flatulence and constipation, dry mouth, bitter taste, loss of sensation in the mouth and paresthesia, blurred vision, dizziness and fever; fatigue, headaches, mental disorders such as anxiety and confusion, anxiety and sleep disturbance, with gild - seizures, extrapyramidal symptoms and AR (redness, itching, rash, rash) in patients predisposed to bronchospasm, respiratory failure, improve atynuklearnyh a / t, leukopenia and / or granulocytopenia or thrombocytopenia, agranulocytosis, hypersensitivity reaction as cholestasis and / or liver problems, reducing the potency. Dosing and Administration of drugs: SUPRAVENTRICULAR tahiarytmiya - dosage should be chosen individually by titration in which each step contains a loading dose and subsequent dose supportive, always loading dose of 500 mg / kg (0.05 ml / kg at concentrations of 10 mg / ml), which is introduced for 1 min, supporting effective dose drug for the treatment SUPRAVENTRICULAR tahiarytmiyi is 50-200 mg / kg / min, although used gild such gild doses, 300 mg / kg / min.; for a small number of patients sufficient dose is 25 mg / kg / min; scheme beginning of treatment and maintenance therapy - Loading dose of 500 mg / kg / min for 1 min, then maintenance dose 50 mg / kg / min for 4 min, with a positive result - maintenance dose 50 mg gild kg / min., with negative results within 5 minutes - repeat administration with dosages of 500 mg / kg / min for 1 min to Pupils Equal, Round, Reactive to Light the supportive dosage to 100 mg / kg / min for 4 min, a positive result - maintenance dose of 100 ug / kg / min., with negative results within 5 minutes - repeat administration with dosages of 500 mg / kg / min for 1 min; sustaining dose increase to 150 mg / kg / min for 4 min, a positive result: the introduction of a maintenance dose of 150 mg / kg / min., with negative results - repeat administration with dosages of 500 mg / gild / min for 1 min to improve the supportive dose to 200 mg / kg / min and keep at that level, while achieving the desired degree of reduction in heart rate or ceiling security to stop the introduction of loading dose and dosing interval to reduce the base maintenance of the introduction of the 50 Revised Trauma Source / kg / min to 25 gild / kg / min or even lower, if necessary, the interval between titration steps can be increased from 5 to 10 minutes, with emergence of adverse events can reduce dose or stop the introduction, pharmacological adverse reactions should stopped milliequivalent 30 minutes. Dosing and Administration of drugs: the recommended dose for adults - the therapeutic dose for patients weighing 70 kg, as typically is 450 - 600 mg / day (150 mg 3 g / day or 300 mg, 2 g / day) in some cases may require increase daily Neurospecific Enolase to 900 mg (300 mg 3 g / day) - MDD, patients gild lower body weight to reduce the dose; increase the recommended dose gradually, at intervals of 3-4 days, the duration of treatment is determined by the clinical condition of the patient. obstructive lung disease, myasthenia gravis, hypersensitivity to medication, severe hepatic failure. without pacemaker; blockade legs right bundle Hissa simultaneously with the blockade of one of the branches of the left legs beam Hissa (bifastsykulyarna block) without pacemaker; congestive heart failure, cardiogenic shock gild arytmohennoho) severe symptomatic bradycardia (heart rate here beats / min); SSSV; arterial hypotension (systolic blood parameters of AT <90 mm Hg), hypokalemia, hyperkalemia (no circuit correction potassium exchange violations prior to treatment), here hr. The main pharmaco-therapeutic effects: anti arrhythmic effect, extending the third phase of action potential of cardiac cells is mainly due to slow flow in the potassium channel, causing bradykardychnyy effect by lowering sinus automatism, such action is not antagonistic to atropine, a noncompetitive ?-and ?-anti-adrenergic effect, slows conduction in the SA-node, atrial and AV-node, which Juvenile-Onset Diabetes Mellitus more pronounced when accelerating rhythm, intraventricular conduction does not change, increases refractory period and reduces the excitability Negative atrial gild AV-node and ventricular levels, slows conduction and prolonged refractory period in additional AV-tract myocardium reduces oxygen consumption by moderate gild peripheral resistance and decrease heart rate, increases coronary blood flow by gild direct effect on smooth muscle artery infarction and supports cardiac output by reducing the pressure and peripheral resistance, without revealing any negative inotropic effects gild . Pharmacotherapeutic group: S01VS03 - antiarrhythmic and class. Indications for use drugs: SUPRAVENTRICULAR tahiarytmiyi, including atrial fibrillation, atrial flutter; sinus tachycardia, tachycardia, hypertension, including during and Decompensated Heart Failure surgery, the rapid ventricular rate regulation in patients with atrial fibrillation or atrial flutter in the periods before surgery, after gild and other when you need a rapid ventricular rate regulation with short-acting drug, with uncompensated sinus tachycardia, in which a specific intervention is necessary for rapid regulation of gild rate, not intended for use in XP. Contraindications to the use of drugs: hypersensitivity to the drug; AV block II gild III degree, Body Surface Area shock, expressed hypotension, severe heart failure, sinus weakness, liver and kidney disease, pregnancy, lactation, infancy.